Home
>
US Stocks
>
Personalis Inc
Personalis Inc
PSNL

Personalis Inc (PSNL)

$18.980.99%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
18.98
Today Low/High
18.77 / 19.38
52 Week Low/High
$16.67 / $53.46
P/E ratio
-15.5311
Market Cap
$780.33M

Company Details

Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA MVP. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient's cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The PersonalisClinical Laboratory is GxP-aligned as well as CLIA'88-certified and CAP-accredited.
Organisation
Personalis Inc
Headquaters
Menlo Park, California, US
Employees
235
Industry
Biotechnology
CEO
John West

Discover more

Frequently Asked Questions

What is Personalis Inc (PSNL) share price today?

Can Indians buy Personalis Inc (PSNL) shares?

How can I buy Personalis Inc (PSNL) shares from India?

Can Fractional shares of Personalis Inc (PSNL) be purchased?

What are the documents required to start investing in Personalis Inc (PSNL) stocks?

We are a SEBI registered investement advisor